Autoimmune pancreatitis

Current Opinion in Gastroenterology

Volumn 24, Issue 5, 2008, Pages 591-596

  Pannala, Rahul ^a   Chari, Suresh T ^a  

^a MAYO CLINIC   (United States)

Author keywords

Autoimmune pancreatitis; Immunoglobulin G4; Immunoglobulin G4 associated systemic disease; Pancreatic mass

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; FLUORODEOXYGLUCOSE F 18; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN G4; IMMUNOMODULATING AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID;

AUTOIMMUNE PANCREATITIS; BILIARY TRACT BIOPSY; CELLULAR IMMUNITY; CHOLANGITIS; CHRONIC PANCREATITIS; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GENETIC ASSOCIATION; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTERSTITIAL PNEUMONIA; LOW DRUG DOSE; OBSTRUCTIVE JAUNDICE; PANCREAS CANCER; PANCREAS RESECTION; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PROGNOSIS; REGULATORY T LYMPHOCYTE; RELAPSE; REMISSION; REVIEW; SEROLOGY; SEX DIFFERENCE; STEROID THERAPY; TH2 CELL; UNSPECIFIED SIDE EFFECT;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; DIAGNOSTIC IMAGING; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INCIDENCE; PANCREATITIS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 55549114030     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32830b10d2     Document Type: Review

References (42)

1. Kamisawa T, Funata N, Hayashi Y. Lymphoplasmacytic sclerosing pancreatitis is a pancreatic lesion of lgG4-related systemic disease. Am J Surg Pathol 2004; 28:1114.
2. Chari ST, Murray JA. Autoimmune pancreatitis. Part II: the relapse. Gastroenterology 2008; 134:625-628.
3. Pickartz T, Mayerle J, Lerch MM. Autoimmune pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2007; 4:314-323. Excellent, comprehensive review of AIP.
4. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995; 40:1561-1568.
5. Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: autoimune pancreatitis: does it exist? Pancreas 2003; 27:1-13.
6. Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol 2007; 42 (Suppl 18): 6-8.
7. Zen Y, Fujii T, Harada K, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangtis. Hepatology 2007; 45:1538-1546. Interesting study on the type of immune response in AIP.
8. Kawa S, Kitahara K, Hamano H, et al. A novel immunoglobulin- immunoglobulin interaction in autoimmunity. PLoS ONE 2008; 3:e1637.
9. Park do H, Kim MH, Oh HB, et al. Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis. Gastroenterology 2008; 134:440-446.
10. Lara LP, Chari ST. Autoimmune pancreatitis. Curr Gastroenterol Rep 2005; 7:101-106.
11. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006; 355:2670-2676.
12. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006; 41:626-631.
13. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006; 4:1010-1016; quiz 934.
14. Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007; 102:2417-2425. First large UK series of patients with AIP.
15. Kajiwara M, Gotohda N, Konishi M, et al. Incidence of the focal type of autoimmune pancreatitis in chronic pancreatitis suspected to be pancreatic carcinoma: experience of a single tertiary cancer center. Scand J Gastroenterol 2008; 43:110-116.
16. Kubota K, Iida H, Fujisawa T, et al. Clinical significance of swollen duodenal papilla in autoimmune pancreatitis. Pancreas 2007; 35:e51-e60.
17. Kim KP, Kim MH, Song MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004; 99:1605-1616.
18. Ito T, Kawabe K, Arita Y, et al. Evaluation of pancreatic endocrine and exocrine function in patients with autoimmune pancreatitis. Pancreas 2007; 34:254-259.
19. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003; 98:2811-2812.
20. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008; 134:706-715. Largest series of IgG4-asociated cholangitis that details clinical profile, relapse rate, and treatment.
21. Umemura T, Zen Y, Hamano H, et al. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 2007; 46:463-471.
22. Sakata N, Tashiro T, Uesugi N, et al. IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am J Surg Pathol 2008; 32:553-559.
23. Cornell LD, Chicano SL, Deshpande V, et al. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 2007; 31:1586-1597.
24. Yamamoto M, Takahashi H, Naishiro Y, et al. Mikulicz's disease and systemic IgG4-related plasmacytic syndrome (SIPS). Nihon Rinsho Meneki Gakkai Kaishi 2008; 31:1-8.
25. Takahashi N, Fletcher JG, Fidler JL, et al. Dual-phase CT of autoimmune pancreatitis: a multireader study. AJR Am J Roentgenol 2008; 190:280-286. Radiological features of AIP and discrimination from pancreatic cancer.
26. Nakazawa T, Ohara H, Sano H, et al. Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest Endosc 2007; 65:99-108.
27. Takahashi N, Kawashima A, Fletcher JG, Chari ST. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 2007; 242:791-801.
28. Nakajo M, Jinnouchi S, Fukukura Y, et al. The efficacy of whole-body FDG-PET or PET/CT for autoimmune pancreatitis and associated extrapancreatic autoimmune lesions. Eur J Nucl Med Mol Imaging 2007; 34:2088-2095.
29. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344:732-738.
30. Ghazale A, Chari ST, Smyrk TC, et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007; 102:1646-1653. Diagnostic operating characteristics of serum IgG4 in AIP and pancreatic cancer.
31. Raina A, Krasinskas AM, Greer JB, et al. Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis. Arch Pathol Lab Med 2008; 132:48-53.
32. Choi EK, Kim MH, Lee TY, et al. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin 64 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience. Pancreas 2007; 35:156-161.
33. Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007; 20:23-28. Demonstration of tissue IgG4 staining to aid in the diagnosis of AIP, first series in western population.
34. Deheragoda MG, Church NI, Rodriguez-Justo M, et al. The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. Clin Gastroenterol Hepatol 2007; 5:1229-1234.
35. Levy MJ, Reddy RP, Wiersema MJ, et al. EUS-guided trucut biopsy in establishing autoimmune pancreatitis as the cause of obstructive jaundice. Gastrointest Endosc 2005; 61:467-472.
36. Bang SJ, Kim MH, Kim do H, et al. Is pancreatic core biopsy sufficient to diagnose autoimmune chronic pancreatitis? Pancreas 2008; 36:84-89.
37. Hirano K, Tada M, Isayama H, et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007; 56:1719-1724. Medium-term natural history study of patients with AIP both with and without steroid treatment.
38. Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007; 56:1650-1652.
39. Ito T, Nishimori I, Inoue N, et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol 2007; 42 (Suppl 18):50-58.
40. Topazian M, Witzig TE, Smyrk TC, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2008; 6:364-366.
41. Ghazale A, Chari S. Is autoimmune pancreatitis a risk factor for pancreatic cancer? Pancreas 2007; 35:376.
42. Inoue H, Miyatani H, Sawada Y, Yoshida Y. A case of pancreas cancer with autoimmune pancreatitis. Pancreas 2006; 33:208-209.